PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CNIO researchers propose a new combined therapy to treat cancer

The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments

2014-02-06
(Press-News.org) Contact information: Nuria Noriega
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
CNIO researchers propose a new combined therapy to treat cancer The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments

A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs—many of which have already been introduced into clinical practice—that permit higher overall survival rates and improvements in the quality of life of cancer patients.

Marcos Malumbres, a researcher at the Spanish National Cancer Research Centre (CNIO), and his team have discovered how etoposide — a drug widely used in the treatment of lung and testicular cancers, leukaemias and brain tumours — could increase its efficiency and specificity in combination with other compounds that interfere with cell division. The results are published today in the journal Cell Reports.

The study has been carried out jointly with the Groups of Óscar Fernández-Capetillo and Javier Muñoz's at the CNIO, and with Hiroyuki Yamano's team at the University College London's Cancer Institute.

Etoposide, a compound obtained from a variant of the mandrake plant, blocks a protein needed for DNA repair during cell division: the Topoisomerase II (TOP2) enzyme. This blocking action increases the damage to genetic material and causes cell death.

Malumbres explains that: "Etoposide affects tumour cells, which are the ones that divide the most and that need TOP2 to repair their DNA, but it also affects healthy cells", adding that: "this lack of specificity causes alterations in healthy tissues that translate into secondary illnesses and toxicity for the organism".

The researchers point out that "the challenge now is to improve the drug's therapeutic window, so that the dose range becomes more effective without increasing toxicity and the secondary effects associated with the treatment".

TREATMENTS TARGETING TUMOUR CELLS

Up until now, data on molecular pathways that govern topoisomerase levels in cells were scarce and did not clarify much. Now, Manuel Eguren, a researcher on Malumbres's team, has, for the first time in animal models and in human cell lines, related TOP2 with the cell division protein regulator Cdh1, so that a decrease in Cdh1 activity increases TOP2 levels in cells.

This study allows for the identification of the formula for increasing TOP2 levels in cells. The research team therefore proposes a new form of effective tumour treatment: the combination of Cdh1 inhibitors (amongst which can be found a substance called proTAME) with etoposide.

"proTAME — which is undergoing preclinical trials to inhibit tumour cell division — could increase the effectiveness of etoposide in cancer cells, those that divide the most and those that therefore have a greater dependency on TOP2 to maintain DNA integrity", say the researchers. This combination of drugs could maximise the anti-neoplastic effect of etoposide and would imply a reduction in the dose and lower toxicity.

Previous studies further indicate that Cdh1 is inactive in some patients due to various oncogenic mutations. "Our data suggest that patient stratification based on their tumour´s Cdh1 status could improve the effect of etoposide in these patients' treatment".

The next step for Malumbres' team is to study this new drug cocktail in patients and to investigate the tumours in which this new therapeutic strategy would be most effective.



INFORMATION:



This project has been funded by the Ministry of Economy and competitiveness, the European Union and the Community of Madrid.



ELSE PRESS RELEASES FROM THIS DATE:

U of T report finds millions of Canadians still struggle to afford food

2014-02-06
Four million Canadians, including 1.15 million children, are living in households where it is sometimes a struggle to put food on the table, according to researchers at the University ...

Fires in Victoria, Australia, Feb. 6, 2014

2014-02-06
Fires in and around Snowy River National Park in Victoria, Australia were captured by the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua satellite on February 06, 2014. Actively burning areas, detected ...

A microchip for metastasis

2014-02-06
Nearly 70 percent of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary ...

Fires in Northern Sumatra

2014-02-06
Fires dot the coast of Northern Sumatra, Indonesia, in this Moderate Resolution Imaging Spectroradiometer (MODIS) satellite image collected on February 06, 2014. The MODIS instrument is aboard the Terra satellite and actively burning ...

RNA sequencing of 750-year-old barley virus sheds new light on the Crusades

2014-02-06
Scientists have for the first time sequenced an ancient RNA genome – of a barley virus once believed to be only 150 years old - pushing its origin back at least 2,000 years and revealing how intense ...

Vanderbilt scientists contribute to finding that could lead to the first effective RSV vaccine

2014-02-06
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective ...

NASA sees Tropical Cyclone Edilson leaving Mauritius

2014-02-06
NASA's Terra satellite saw Tropical Cyclone Edilson pulling away from the island of Mauritius in the Southern Indian Ocean when it passed overhead on February 6, 2014. The Moderate Resolution Imaging Spectroradiometer ...

Heart health through gut health

2014-02-06
A new study, "Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets," published in the January issue of Nutrition ...

New investigational drug holds promise for combatting deadly mucormycosis infections

2014-02-06
LOS ANGELES – (Feb. 6, 2014) – With very few treatment options available ...

Quick test finds signs of diarrheal disease

2014-02-06
Bioengineers at Rice University and the University of Texas Medical Branch (UTMB) at Galveston have developed a simple, highly sensitive and efficient test for the diarrheal disease ...

LAST 30 PRESS RELEASES:

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

[Press-News.org] CNIO researchers propose a new combined therapy to treat cancer
The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments